Methyl and bromo derivatives of estradiol are agonistic ligands for the estrogen receptor of MCF-7 breast cancer cells

J Steroid Biochem Mol Biol. 1991 Sep;39(3):359-66. doi: 10.1016/0960-0760(91)90047-9.

Abstract

The binding affinity and relative estrogenic potency of 2-bromo-, 4-bromo-, 2-methyl- and 4-methylestradiol was evaluated in MCF-7 breast cancer cells. The relative binding affinities compared to estradiol were 47% for 2-methyl-, 25% for 4-methyl-, 37% for 4-bromo- and 17% for 2-bromoestradiol. However, both 2- and 4-methyl- as well as 2- and 4-bromoestradiol were able (a) to translocate the cytosolic estrogen receptor into the nucleus and (b) to induce the progesterone receptor in a concentration dependent manner. Finally, all ring-A substituted estrogens used in this study induced the pS2 mRNA as demonstrated by Northern-blotting. From these findings we conclude that 2-bromo-, 4-bromo-, 2-methyl- and 4-methylestradiol are agonistic ligands for the estrogen receptor in MCF-7 breast cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Northern
  • Breast Neoplasms
  • Down-Regulation
  • Estradiol / analogs & derivatives*
  • Estradiol / metabolism
  • Humans
  • RNA, Messenger / analysis
  • RNA, Messenger / biosynthesis
  • Receptors, Estrogen / metabolism*
  • Receptors, Progesterone / metabolism
  • Substrate Specificity
  • Tumor Cells, Cultured

Substances

  • RNA, Messenger
  • Receptors, Estrogen
  • Receptors, Progesterone
  • 2-methylestradiol
  • Estradiol
  • 4-methylestradiol